Many Drugmakers Ignore Trump—and Raise Prices Anyway

President Donald Trump succeeded in convincing Pfizer Inc. to hold off on price increases it had planned for this month. But the pharmaceutical giant wasn’t the only drug company seeking to charge more for its products in recent days.In the first 10 days of July, at least ten other drugmakers and biotechnology companies raised prices on at least 20 brand-name medicines, a review of pricing data from Rx Savings Solutions and Bloomberg Intelligence shows.